Jamieson Wellness (TSE:JWEL) Shares Down 0.1% - What's Next?

Key Points

• Jamieson Wellness shares slipped 0.1% to C$45.49 in Friday trading, while volume surged 123% above the average daily level.
• Analyst sentiment has weakened, with several firms downgrading the stock; the consensus rating is now Hold, with an average price target of C$46.07.
• The company increased its quarterly dividend to $0.25 per share, implying an annualized dividend of $1.00 and a 2.2% yield; its latest quarter included C$0.46 EPS and C$233.84 million in revenue.

Shares of Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) traded down 0.1% on Friday. The company traded as low as C$45.47 and last traded at C$45.49. Approximately 338,716 shares traded hands during mid-day trading, an increase of 123% from the average daily volume of 151,723 shares. The stock had previously closed at C$45.53.

Wall Street Analyst Weigh In

JWEL has been the topic of a number of recent analyst reports. Canaccord Genuity Group downgraded Jamieson Wellness from a "buy" rating to a "hold" rating and boosted their price target for the stock from C$44.50 to C$45.75 in a research report on Monday, August 10th. Canadian Imperial Bank of Commerce cut shares of Jamieson Wellness from an "outperformer" rating to a "tender" rating and lifted their price objective for the stock from C$44.00 to C$45.75 in a research note on Friday, August 7th. National Bank Financial cut Jamieson Wellness from an "outperform" rating to a "tender" rating and decreased their price target for the stock from C$51.00 to C$45.75 in a research report on Monday, August 31st. TD cut Jamieson Wellness from a "hold" rating to a "sell" rating and cut their target price for the stock from C$49.00 to C$45.75 in a research note on Friday, October 2nd. Finally, Stifel Nicolaus lowered shares of Jamieson Wellness from a "buy" rating to a "hold" rating and lifted their price target for the company from C$45.00 to C$45.75 in a report on Friday, August 7th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Jamieson Wellness has an average rating of "Hold" and an average target price of C$46.07.

Jamieson Wellness Stock Performance

The stock has a market capitalization of C$1.89 billion, a P/E ratio of 24.86 and a beta of 1.37. The company has a 50-day moving average price of C$45.50 and a two-hundred day moving average price of C$40.49. The company has a current ratio of 3.41, a quick ratio of 1.08 and a debt-to-equity ratio of 93.69.

Jamieson Wellness (TSE:JWEL - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported C$0.46 earnings per share (EPS) for the quarter. Jamieson Wellness had a return on equity of 15.93% and a net margin of 8.92%. The firm had revenue of C$233.84 million for the quarter. On average, equities analysts forecast that Jamieson Wellness Inc. will post 2.14 earnings per share for the current year.

Jamieson Wellness Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 15th were paid a dividend of $0.25 per share. This is an increase from Jamieson Wellness's previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Monday, August 31st. This represents a $1.00 dividend on an annualized basis and a yield of 2.2%. Jamieson Wellness's dividend payout ratio (DPR) is currently 50.27%.

Jamieson Wellness Company Profile

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.